FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077536997> ?p ?o ?g. }

• W2077536997 endingPage "626" @default.
• W2077536997 startingPage "613" @default.
• W2077536997 abstract "There is growing evidence that docetaxel, a microtubule-targeting agent like the other taxane paclitaxel, induces dual cytotoxicity mechanism according to dose level. Postgenomics screening technologies are now more and more applied to the elucidation of drug response mechanisms. Proton nuclear magnetic resonance spectroscopy-based pharmacometabolomics was here applied to get further insight into the response of human MCF7 breast carcinoma cells to docetaxel at high (clinical, 5 microM) and low (1 nM) doses. The global response to both doses was evaluated by nuclear morphology and DNA content, the latter as an index of cell proliferation and DNA ploidy. High dose provoked long-lasting cell cycle arrest in mitosis during the first 48 h of exposure to treatment and severe decrease in DNA content followed by significant amount of cell death. In contrast, at low dose, no long-lasting cell cycle arrest was observed on micrographies, and DNA content was decreased but less than at high dose (P < 0.05), without significant cell death. This response was compared to biochemical alteration assessed by pharmacometabolomics. Thirty metabolites were identified and quantified. Metabolite profiling at clinical dose revealed time-dependent disorders in derivatives of glycolysis, lipid metabolism and glutathione metabolism. Comparison between high and low doses was performed at 72 h and showed common traits including the accumulation of cytidinediphosphocholine (x 5.0 and x 6.9, respectively, P < 0.03), the decrease in phosphatidylcholine (x 0.3 and x 0.2, respectively, P < 0.03), and gluthathione (x 0.6 and x 0.6, respectively, P < 0.03). Despite that, significant dose-dependent differences were found in 12 of 30 measured metabolites. Among them, the most discriminant metabolites were polyunsaturated fatty acids (ratio of high-to-low dose of 14.8, P < 0.05), glutamate, myoinositol, and homocysteine (ratio < 0.4, P < 0.05). In addition, the mechanism for glutathione decrease was different. At high dose, it resulted from extensive consumption with precursor starvation (glutamate: -89%, P < 0.05) and increased glutathione S-transferase activity (x 5, P < 0.01), whereas at low dose, it resulted from glutathione biosynthesis blockade with homocysteine accumulation (+144%, P < 0.03) and decreased glutathione S-transferase activity (-70%, P < 0.01). Altogether, this pharmacometabolomics analysis provides further evidence of the varying cellular responses at high and low doses of docetaxel in MCF7 breast cancer cells." @default.
• W2077536997 created "2016-06-24" @default.
• W2077536997 creator A5009054255 @default.
• W2077536997 creator A5064696564 @default.
• W2077536997 creator A5072502548 @default.
• W2077536997 creator A5090100742 @default.
• W2077536997 date "2009-06-10" @default.
• W2077536997 modified "2023-10-03" @default.
• W2077536997 title "Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses" @default.
• W2077536997 cites W1524236554 @default.
• W2077536997 cites W1581414347 @default.
• W2077536997 cites W1841504999 @default.
• W2077536997 cites W1968111138 @default.
• W2077536997 cites W1968747252 @default.
• W2077536997 cites W1970226410 @default.
• W2077536997 cites W1971255279 @default.
• W2077536997 cites W1977573119 @default.
• W2077536997 cites W1981765582 @default.
• W2077536997 cites W1987141787 @default.
• W2077536997 cites W1987496015 @default.
• W2077536997 cites W1991134224 @default.
• W2077536997 cites W1996069354 @default.
• W2077536997 cites W2002870564 @default.
• W2077536997 cites W2006668556 @default.
• W2077536997 cites W2012847857 @default.
• W2077536997 cites W2015536907 @default.
• W2077536997 cites W2016301784 @default.
• W2077536997 cites W2017684900 @default.
• W2077536997 cites W2020902432 @default.
• W2077536997 cites W2022252098 @default.
• W2077536997 cites W2028912233 @default.
• W2077536997 cites W2039114029 @default.
• W2077536997 cites W2043061492 @default.
• W2077536997 cites W2043478531 @default.
• W2077536997 cites W2043574981 @default.
• W2077536997 cites W2049769334 @default.
• W2077536997 cites W2052746044 @default.
• W2077536997 cites W2059686889 @default.
• W2077536997 cites W2061298782 @default.
• W2077536997 cites W2062077798 @default.
• W2077536997 cites W2063783903 @default.
• W2077536997 cites W2068344719 @default.
• W2077536997 cites W2071213773 @default.
• W2077536997 cites W20829919 @default.
• W2077536997 cites W2084192782 @default.
• W2077536997 cites W2109637975 @default.
• W2077536997 cites W2116285544 @default.
• W2077536997 cites W2120526364 @default.
• W2077536997 cites W2141056749 @default.
• W2077536997 cites W2141970041 @default.
• W2077536997 cites W2142104643 @default.
• W2077536997 cites W2143919324 @default.
• W2077536997 cites W2156394189 @default.
• W2077536997 cites W2166817392 @default.
• W2077536997 cites W2411898530 @default.
• W2077536997 cites W4241166158 @default.
• W2077536997 doi "https://doi.org/10.1007/s10549-009-0430-1" @default.
• W2077536997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19513827" @default.
• W2077536997 hasPublicationYear "2009" @default.
• W2077536997 type Work @default.
• W2077536997 sameAs 2077536997 @default.
• W2077536997 citedByCount "37" @default.
• W2077536997 countsByYear W20775369972012 @default.
• W2077536997 countsByYear W20775369972013 @default.
• W2077536997 countsByYear W20775369972015 @default.
• W2077536997 countsByYear W20775369972016 @default.
• W2077536997 countsByYear W20775369972018 @default.
• W2077536997 countsByYear W20775369972020 @default.
• W2077536997 countsByYear W20775369972021 @default.
• W2077536997 countsByYear W20775369972022 @default.
• W2077536997 countsByYear W20775369972023 @default.
• W2077536997 crossrefType "journal-article" @default.
• W2077536997 hasAuthorship W2077536997A5009054255 @default.
• W2077536997 hasAuthorship W2077536997A5064696564 @default.
• W2077536997 hasAuthorship W2077536997A5072502548 @default.
• W2077536997 hasAuthorship W2077536997A5090100742 @default.
• W2077536997 hasBestOaLocation W20775369972 @default.
• W2077536997 hasConcept C121608353 @default.
• W2077536997 hasConcept C126322002 @default.
• W2077536997 hasConcept C134018914 @default.
• W2077536997 hasConcept C143425029 @default.
• W2077536997 hasConcept C1491633281 @default.
• W2077536997 hasConcept C181199279 @default.
• W2077536997 hasConcept C185592680 @default.
• W2077536997 hasConcept C190283241 @default.
• W2077536997 hasConcept C2777292972 @default.
• W2077536997 hasConcept C2777477808 @default.
• W2077536997 hasConcept C2777511904 @default.
• W2077536997 hasConcept C2781190966 @default.
• W2077536997 hasConcept C29537977 @default.
• W2077536997 hasConcept C31573885 @default.
• W2077536997 hasConcept C502942594 @default.
• W2077536997 hasConcept C530470458 @default.
• W2077536997 hasConcept C538909803 @default.
• W2077536997 hasConcept C552990157 @default.
• W2077536997 hasConcept C55493867 @default.
• W2077536997 hasConcept C62112901 @default.
• W2077536997 hasConcept C71924100 @default.

• next